Topamax and Peppermint drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Topamax (topiramate) and Peppermint (peppermint). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Topamax and Peppermint. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Topamax?

Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 58,955 Topamax users. Check the latest studies of Topamax.

What is Peppermint?

Peppermint has active ingredients of peppermint. eHealthMe is studying from 1,327 Peppermint users. Check the latest studies of Peppermint.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

13 people who take Topamax and Peppermint together, and have interactions are studied.

Topamax and Peppermint drug interactions.

What are the common drug interactions of Topamax and Peppermint, by gender? *:

female:

Fatigue (feeling of tiredness)
Headache (pain in head)
Rash
Upper respiratory tract infection
Body temperature increased
Chills (felling of cold)
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Viral infection
Neoplasm malignant (cancer tumour)

male:

n/a

What are the common drug interactions of Topamax and Peppermint, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Body temperature increased
Chills (felling of cold)
Diarrhoea
Dizziness
Fatigue (feeling of tiredness)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Headache (pain in head)
Insomnia (sleeplessness)
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)

30-39:

Headache (pain in head)
Insomnia (sleeplessness)
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Neutropenia (an abnormally low number of neutrophils)
Pruritus (severe itching of the skin)
Rash
Upper respiratory tract infection

40-49:

n/a

50-59:

Jc virus infection
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

60+:

Drug ineffective
Insomnia (sleeplessness)

What are the existing conditions these people have? *

Upper Respiratory Tract Infection: 5 people, 38.46%
Multiple Myeloma (cancer of the plasma cells): 5 people, 38.46%
Immunodeficiency Common Variable: 3 people, 23.08%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
Light Chain Disease (a rare blood cell disease which is characterized by deposition of fragments of infection-fighting immunoglobulins): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Topamax and Peppermint?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously